Skip to content

DR. C. RABET

Active
Private limited companyfounded 2003active for 23 yearsVeldstraat 55, 2450 Meerhout, BelgiumKBO/BCE: BE 0859.789.291
Summary

DR. C. RABET has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €646,705 and a net result of €202,222. Equity has been growing by about 28% per year since 2018. Its solvency ranks better than 89% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-07-2003 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.302.282.132 2450 Meerhout, since 28-07-2003
Financial year end
31 December
Peppol
Reachable since 20-03-2025

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€279,866
▲ 17.4%
Turnover
≈ €430,000
estimated
Profit
€202,222
▲ 20.5%
Equity
€646,705
▼ 10.0%
Total assets
€690,189
▼ 11.2%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 15.72, cash €187,425Equity €646,705 (93.7% of total assets)Size: total assets €690,189Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 93.7% of total assets
Liquidity 84+14
short-term debt 6.3% · cash 27.2%
Profitability 100+4
return on assets 29.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 15.72 (13.19 in 2024), above the usual 1.5. Short-term debt is 6.3% and cash 27.2% of total assets. 6.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 66% on liquidity, 80% on profitability and 26% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 15.72, cash €187,425
NBB · annual accounts
lowers risk · Equity €646,705 (93.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €690,189
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 days early
2024
55 days early
2023
40 days early
2022
76 days early
2021
72 days early
2020
37 days early
2019
18 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 47 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 89% of companies in human healthsector median 63.0% · 20,706 companies 93.7% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €202,222 8 years View

Recent changes

  1. · Gazette deed Change of role: RABET,Christiane Rosa Françoise, from manager to director
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as DR. C. RABET: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €634,000 and €743,000, founded between 2003 and 2005.

CompanyTotal assetsGross margin
DR. C. RABET Meerhout€690,189€279,866
Dr Tina Vanderheyden Antwerpen€738,236€287,518
DR. ROMBOUTS Rumst€738,282€253,563
Dr. Vincent Martens Antwerpen€742,670€248,400
C LE A R V I S I O N Ukkel€634,385€274,676
EL ALAMI Sint-Pieters-Woluwe€639,991€268,046
JAMAR SOPHIE Genappe€636,288€273,749
Full comparison

Key facts about DR. C. RABET

What is the company number of DR. C. RABET?
The company number of DR. C. RABET is 0859.789.291. The VAT number is the same number with BE in front: BE 0859.789.291.
Where is DR. C. RABET based?
The registered office is at Veldstraat 55, 2450 Meerhout.Company details
What does DR. C. RABET do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. C. RABET?
The legal form of DR. C. RABET is Private limited company (BV).
When was DR. C. RABET founded?
DR. C. RABET was founded on 28-07-2003.
Is DR. C. RABET still active?
Yes, DR. C. RABET is an active enterprise in the KBO register.
What is the turnover of DR. C. RABET?
The turnover in financial year 2025 is ≈ €430,000. This figure is estimated from the gross margin of €279,866 and 36 comparable companies (NACE 862). It probably lies between €390,000 and €540,000.Financials
Is DR. C. RABET profitable?
In financial year 2025, DR. C. RABET made a profit of €202,222.
Where can I find the annual accounts of DR. C. RABET?
DR. C. RABET filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. C. RABET due?
DR. C. RABET must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.